PharmaBoardroom

The Cell & Gene Therapy Market: Excitement Abounds

David H. Crean, Managing General Partner for Coast BioVentures, updates and highlights the latest trends in the cell and gene therapy market for deal…

PharmaBoardroom’s Top Five Op-Eds of 2021

PharmaBoardroom's network of thought leaders provided some of our best-read content in 2021 on topics ranging from China's National Reimbursement Drug…

Top 10 Medtech Companies 2021

The Top 10 global medical device companies, ranked by sales in USD billions for 2021, as selected by Medical Product Outsourcing. The list is…

Genmab CEO On 50:50 Partnerships & Creating “Iconic”…

Europe lags behind the US in terms of biotech success stories, but one company bucking that trend is Denmark-headquartered Genmab, with a market cap…

5 Things to Know about the Life Sciences in Catalonia

A rundown of five things to know about the healthcare and life sciences industry in Catalonia. Nestled in Northeastern Spain and bordering France,…

The Global Pandemic Agreement: Time to Get Serious

Shawview Consulting's Brendan Shaw laments the descent into nationalism that COVID-19 - like past pandemics - has led to, and outlines his hopes that…

Jan van de Winkel – President & CEO, Genmab

Speaking exclusively to PharmaBoardroom, Jan van de Winkel highlights the tremendous progress that European biotech success story Genmab has made over…

A ‘Bold Vision’ of CAR-T Patient Engagement

Marc Boutin, Novartis’ global head of patient engagement, outlines the company’s “bold vision” of patient engagement and the actions that need…

Top 10 Korean Pharma Companies 2021

The top 10 pharma companies in South Korea ranked by revenues in the first half of 2021. Yuhan Corporation sits in top spot, followed by Kolmar and GC…

Lars Georg Rust – Regional Managing Director North, Olympus

Lars Georg Rust outlines Olympus' transition into fully-fledged MedTech company, the relevance of the Nordics and Netherlands to the global group, and…

Pharma Faces: Zealand’s Emmanuel Dulac Targeting 5…

Although Zealand Pharma has been around for 23 years, it has made rapid progress since French national Emmanuel Dulac took the helm as president and…

France Pharma Roundup: Owkin Becomes Unicorn; Sanofi/Baidu Tie-up…

The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment…

Tagged with OP